Nachweis von SLA/LP-Autoantikörpern bei Patienten mit primär biliärer Zirrhose als Marker für eine sekundäre autoimmune Hepatitis (Overlapsyndrom)
The DOI matches its Crossref record, with a small difference in title or year.
Abstract
Hintergrund und Fragestellung: Ziel der vorliegenden Studie war es, zu untersuchen, inwieweit der Nachweis von anti-SLA/LP-Autoantikörper bei Patienten mit primär biliärer Zirrhose einen Hinweis auf eine hepatitische Verlaufsform bzw. ein Autoimmune Hepatitis/Primär biliäre Zirrhose(AIH/PBC)-Overlapsyndrom gibt. Patienten und Methodik: Aus 233 konsekutiven PBC-Patienten, die zwischen Oktober 1980 und April 2000 betreut worden waren, wurden die Daten anti-SLA/LP-positiver Patienten ausgewertet und mit Verläufen von Patienten mit anti-SLA/LP-negativem AIH/PBC-Overlapsyndrom sowie mit klassischer Verlaufsform einer PBC und AIH verglichen. Ergebnisse: Insgesamt konnten neun PBC-Patienten (sechs Frauen/drei Männer) oder 3,9 % des Patientenkollektivs identifiziert werden, die anti-SLA/LP-Autoantikörper aufwiesen. Diese waren bei Diagnosestellung etwas jünger als anti-SLA/LP-negative PBC-Patienten (49,9 vs. 53,2 Jahre). Transaminasen und γ-Globuline lagen bei den anti-SLA/LP-positiven PBC-Patienten deutlich höher als bei anti-SLA/LP-negativen PBC-Patienten (Mittelwert : 235 vs. 55 IU/l und 27,6 vs. 19,5 g/l). Anti-SLA/LP-positive Patienten wiesen signifikant häufiger einen für die AIH typischen HLA-Typ auf (B8; DR3; DR4). Eine immunsuppressive Therapie führte zu einer deutlichen Abnahme der entzündlichen Aktivität und der laborchemischen Cholestase. Nach Reduktion oder Absetzen der Immunsuppression waren Rezidive häufig. Folgerung: Der Nachweis von anti-SLA/LP-Antikörpern bei PBC-Patienten ist hochspezifisch für das Vorliegen eines AIH/PBC-Overlapsyndrom. Diese Patienten sprechen gut auf eine immunsuppressive Therapie an. Das Autoantikörperprofil und die Immungenetik könnten in Zukunft weiterhelfen, PBC-Patienten zu identifizieren, die besonders von einer immunsuppressiven Therapie profitieren. Presence of SLA/LP-autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndome) Background and objective: The aim of this study was to evaluate whether the presence of SLA/LP-autoantibodies in PBC-patients gives evidence for a secondary AIH, also called AIH/PBC-overlap-syndrome. Patients and methods: Out of 233 consecutive patients with PBC who had been followed between October 1980 and April 2000, we evaluated the data of anti-SLA/LP-positive patients and compared them to patients with an anti-SLA/LP-negative AIH/PBC overlap syndrome as well as to patients with a classical course of AIH and PBC. Results: In total we could identify nine PBC patients with anti-SLA/LP antibodies (six women/three men) or 3.9 % of the study population. Anti-SLA/LP-positive PBC patients were slightly younger at diagnosis in comparison to anti-SLA/LP-negative PBC-patients (49,9 vs. 53.2 years). Transaminases and γ-globulins were significantly higher in anti-SLA/LP-positive PBC-patients in comparison to anti-SLA/LP-negative PBC-patients (mean: 235 vs. 55 IU/l and 27.6 vs. 19.5 g/l). Anti-SLA/LP-positive patients significantly more frequently had an HLA-type that is characteristic for AIH (B8; DR3; DR4). Immunosuppressive therapy reduced inflammatory activity and cholestasis significantly. Relapses were frequent after reduction or discontinuation of immunosuppressive therapy. Conclusion: The presence of SLA/LP autoantibodies in PBC patients has a high specificity for a secondary AIH (AIH/PBC overlap syndrome). These patients have a good response to immunosuppressive therapy. The autoantibody profile and immunogenetics may help in future to identify PBC patients that benefit most from immunosuppressive therapy. 1 Die AIH- und PBC-Patienten, mit den die hier beschriebenen anti-SLA/LP-positiven PBC-Patienten verglichen wurden, entstammen aus der Veröffentlichung: Lohse et al.; Hepatology 1999; 29: 1078-1084.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Still being checked.
Cited by
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Boberg, K. M., Chapman, R. W., Hirschfield, G. M., Lohse, A. W., Manns, M. P., & Schrumpf, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.002 · Cited by 555
“Even anti-SLA/LP is not entirely specific for AIH and has also been detected in cases of PBC or PSC, albeit in association with features of AIH [19–23].”
BackgroundSelf-citationDevelopment of autoimmune hepatitis in patients with typical primary biliary cirrhosis
Poupon, R., Chazouilleres, O., Corpechot, C., & Chrétien, Y. (2006) · Hepatology · doi:10.1002/hep.21229 · Cited by 170
Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance
Sebode, M., Weiler-Normann, C., Liwinski, T., & Schramm, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00609 · Cited by 158
Overlap syndromes among autoimmune liver diseases
Rust, C., & Beuers, U. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3368 · Cited by 158
Autoimmune liver disease: overlap and outliers
Washington, M. K. (2007) · Modern Pathology · doi:10.1038/modpathol.3800684 · Cited by 129
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome
Muratori, P., Granito, A., Pappas, G., Pendino, G. M., Quarneti, C., Cicola, R., Menichella, R., Ferri, S., Cassani, F., Bianchi, F. B., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.126 · Cited by 125
The challenges of primary biliary cholangitis: What is new and what needs to be done
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., Vergani, D., Vierling, J. M., Adams, D., Alpini, G., Banales, J. M., Beuers, U., Björnsson, E., Bowlus, C., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102328 · Cited by 114
Update in clinical science: Autoimmune hepatitis
Heneghan, M. A., & Lohse, A. W. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2024.12.041 · Cited by 80
Self-citationBeuers, U. H. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.009 · Cited by 61
Autoimmune hepatitis and overlap syndromes
Dienes, H. P., Erberich, H., Dries, V., Schirmacher, P., & Lohse, A. W. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00007-7 · Cited by 61
Self-citationPrimary biliary cirrhosis: What do autoantibodies tell us?
Hu, C.-J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i29.3616 · Cited by 60
The Hepatitic/Cholestatic "Overlap" Syndrome: An Italian Experience
Muratori, L., Cassani, F., Pappas, G., Guidi, M., Mele, L., VERONESI, L., Lenzi, M., Bianchi, F. B., & Muratori, P. (2002) · Autoimmunity · doi:10.1080/0891693021000064272 · Cited by 51
Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis
Stinton, L. M., Swain, M. G., Myers, R. P., Shaheen, A. A., & Fritzler, M. J. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04288.x · Cited by 48
Overlap Syndromes of Cholestatic Liver Diseases and Auto-Immune Hepatitis
Schramm, C., & Lohse, A. W. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:2:105 · Cited by 37
Self-citationVariant and Specific Forms of Autoimmune Cholestatic Liver Diseases
Dalekos, G. Ν., & Gatselis, N. (2019) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-019-00550-9 · Cited by 23
Variant syndromes of primary biliary cholangitis
Schulz, L., Sebode, M., Weidemann, S. A., & Lohse, A. W. (2018) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2018.06.003 · Cited by 18
Self-citationAntibodies and primary biliary cirrhosis – piecing together the jigsaw
Neuberger, J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00303-8 · Cited by 16
Primary biliary cholangitis: current insights and novel therapies
Granito, A., Παππάς, Γ., Napoli, L., Stefanini, B., Tirotta, D., & Muratori, P. (2026) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2026.2672493 · Cited by 10
Overlap syndromes: An emerging diagnostic and therapeutic challenge
Malhotra, S., & Dhiman, P. (2014) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.145316 · Cited by 8
(2016) · Springer Publishing Company eBooks · doi:10.1891/9780826117496.0019 · Cited by 8
Lohse, A. W., & Weiler‐Normann, C. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.032 · Cited by 6
Self-citationBeuers, U. H., & Rust, C. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-518-3_23 · Cited by 3
Primary Biliary Cirrhosis: Autoimmune Hepatitis Overlap Syndrome
Iezzoni, J. C. (2010) · Pathology Case Reviews · doi:10.1097/pcr.0b013e3181df4334 · Cited by 3
Defendenti, C., Bollani, S., Munegato, G., Saibeni, S., Sofia, M., Bruno, S., Saudelli, M., & Picca, M. (2008) · Microbiologia medica · doi:10.4081/mm.2008.2580 · Cited by 2
AUTOIMMUNE HEPATITIS: DIAGNOSTIC CHALLENGES AND RISK FACTORS – A NARRATIVE REVIEW
Góral, M., Bednarczuk, K., Skuza, A. I., Downar-Zapolska, M., Sergiel, K. H., Torbacka, E., Fidorowicz, D., Sagan, D., Siedlecki, R., & Mikłaszewicz, A. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5373
Dancygier, H. (2009) · Springer eBooks · doi:10.1007/978-3-642-04519-6_23
Dancygier, H. (2003) · Springer eBooks · doi:10.1007/978-3-642-55902-0_25
Beuers, U. H. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch11e
Liver histology in autoimmune hepatitis — diagnostic implications
Dienes, H. P. (2007) · Springer eBooks · doi:10.1007/1-4020-2914-4_14
Self-citationOverlap syndromes in hepatic autoimmune diseases
Podzolkov, V. I., Dragomiretskaya, N. A., Volchkova, E. V., & Mitrokhina, O. I. (2017) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2017-95-10-940-945
Colangiopatía autoinmune: criterios diagnósticos actuales
Sánchez-Muñoz, D., & Romero‐Gómez, M. (2007) · Revista Andaluza de Patología Digestiva
Autoantibodies to SLA/LP: specificity and pathogenetic relevance?
Cheruti, U., Wang, C., Lohse, A. W., & Herkel, J. (2007) · Springer eBooks · doi:10.1007/1-4020-2914-4_8
Self-citation
Metadata
- Authors
- Kanzler, S., Bozkurt, S., Herkel, J., Galle, P., Dienes, H., & Lohse, A.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- University of Cologne (DE)
- Venue
- DMW - Deutsche Medizinische Wochenschrift
- Publisher
- Georg Thieme Verlag KG
- Published
- 2001-12-31
- Volume
- 126
- Issue
- 16
- Pages
- 450-456
- ISSN
- 0012-0472 (ISSN-L)
- 1439-4413
- OpenAlex
- W2410168206
- Semantic Scholar
- 1de2abc3c08604d8a840dac00b6ea585e1f33186
- Cited by
- 33
- References
- 0
- Citations by year
- 2026: 2 · 2025: 1 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 1 · 2014: 1 · 2013: 1
- FWCI
- 1.24
- Type
- journal article
- Language
- de
- Open access
- closed
- Locations
- DMW - Deutsche Medizinische Wochenschrift (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary biliary cirrhosis, autoimmune hepatitis, HLA class II association, HLA-B8, HLA-DR3, HLA-DR4, immunosuppressive therapy, relapse, cholestasis, serological diagnosis, age at diagnosis, transaminases
- MeSH terms
- Adult, Aged, Transaminases, Autoantibodies, Biopsy, Data Interpretation, Statistical, Clinical Enzyme Tests, Enzyme-Linked Immunosorbent Assay, Female, Fluorescent Antibody Technique, Follow-Up Studies, gamma-Globulins, Humans, Immunosuppressive Agents, Liver, Liver Cirrhosis, Biliary, Male, Middle Aged, Time Factors, Blotting, Western, Hepatitis, Autoimmune
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.